Eun-Kyu Koh to Imatinib Mesylate
This is a "connection" page, showing publications Eun-Kyu Koh has written about Imatinib Mesylate.
Connection Strength
0.027
-
A Phase I clinical trial of the combination of imatinib and paclitaxel in patients with advanced or metastatic solid tumors refractory to standard therapy. Cancer Chemother Pharmacol. 2012 Dec; 70(6):843-53.
Score: 0.027